ACIP Meetings
:: November 2-3, 2021


Press Announcements
November 5, 2021 – Coronavirus (COVID-19) Update: November 5, 2021
:: Today, Friday, November 5, 2021, the FDA authorized the use, under the EUA for the Janssen COVID-19 Vaccine, of two additional batches of vaccine drug substance manufactured at the Emergent facility…
:: On Monday, November 1, 2021, Acting FDA Commissioner Janet Woodcock, M.D. and the Director of FDA’s Center for Biologics Evaluation and Research Peter Marks, M.D., Ph.D., discussed the FDA’s EUA of the Pfizer-BioNTech COVID-19 Vaccine for children 5 through 11 years of age. Health care professionals, patient advocacy groups, trade associations, consumer organizations, national immunization organizations and state and local public health organizations were invited to the call. To watch the video, visit the FDA’s YouTube channelExternal Link Disclaimer.

November 2, 2021 – Coronavirus (COVID-19) Update: November 2, 2021


Vaccines and Related Biological Products Advisory Committee– FDA
No meetings on calendar